191 related articles for article (PubMed ID: 32329510)
1. Role of PARP1 regulation in radiation-induced rescue effect.
Pathikonda S; Cheng SH; Yu KN
J Radiat Res; 2020 May; 61(3):352-367. PubMed ID: 32329510
[TBL] [Abstract][Full Text] [Related]
2. Unirradiated cells rescue cells exposed to ionizing radiation: Activation of NF-κB pathway in irradiated cells.
Lam RK; Han W; Yu KN
Mutat Res; 2015 Dec; 782():23-33. PubMed ID: 26524645
[TBL] [Abstract][Full Text] [Related]
3. NF-κB and Poly (ADP-ribose) Polymerase 1 Form a Positive Feedback Loop that Regulates DNA Repair in Acute Myeloid Leukemia Cells.
Li D; Luo Y; Chen X; Zhang L; Wang T; Zhuang Y; Fan Y; Xu J; Chen Y; Wu L
Mol Cancer Res; 2019 Mar; 17(3):761-772. PubMed ID: 30559256
[TBL] [Abstract][Full Text] [Related]
4. Induction of autophagy and interleukin 6 secretion in bystander cells: metabolic cooperation for radiation-induced rescue effect?
Kong EY; Cheng SH; Yu KN
J Radiat Res; 2018 Mar; 59(2):129-140. PubMed ID: 29385614
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions.
Kwon M; Jang H; Kim EH; Roh JL
Cell Cycle; 2016 Nov; 15(22):3105-3114. PubMed ID: 27686740
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced rescue effect.
Yu KN
J Radiat Res; 2019 Mar; 60(2):163-170. PubMed ID: 30624744
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1.
Hulse M; Caruso LB; Madzo J; Tan Y; Johnson S; Tempera I
PLoS Pathog; 2018 Nov; 14(11):e1007394. PubMed ID: 30395643
[TBL] [Abstract][Full Text] [Related]
8. Exendin-4 Ameliorates Cardiac Remodeling in Experimentally Induced Myocardial Infarction in Rats by Inhibiting PARP1/NF-κB Axis in A SIRT1-Dependent Mechanism.
Eid RA; Alharbi SA; El-Kott AF; Eleawa SM; Zaki MSA; El-Sayed F; Eldeen MA; Aldera H; Al-Shudiefat AAS
Cardiovasc Toxicol; 2020 Aug; 20(4):401-418. PubMed ID: 32193876
[TBL] [Abstract][Full Text] [Related]
9. The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation.
Faraoni I; Aloisio F; De Gabrieli A; Consalvo MI; Lavorgna S; Voso MT; Lo-Coco F; Graziani G
Cancer Lett; 2018 Jun; 423():127-138. PubMed ID: 29526802
[TBL] [Abstract][Full Text] [Related]
10. PARP Inhibitor Protects Against Chronic Hypoxia/Reoxygenation-Induced Retinal Injury by Regulation of MAPKs, HIF1α, Nrf2, and NFκB.
Kovacs K; Vaczy A; Fekete K; Kovari P; Atlasz T; Reglodi D; Gabriel R; Gallyas F; Sumegi B
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1478-1490. PubMed ID: 30973576
[TBL] [Abstract][Full Text] [Related]
11. A rapid fluorescent method for the real-time measurement of poly(ADP-ribose) polymerase 1 activity.
Kurgina TA; Anarbaev RO; Sukhanova MV; Lavrik OI
Anal Biochem; 2018 Mar; 545():91-97. PubMed ID: 29326071
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
[TBL] [Abstract][Full Text] [Related]
13. A functional ex vivo assay to detect PARP1-EJ repair and radiosensitization by PARP-inhibitor in prostate cancer.
Köcher S; Beyer B; Lange T; Nordquist L; Volquardsen J; Burdak-Rothkamm S; Schlomm T; Petersen C; Rothkamm K; Mansour WY
Int J Cancer; 2019 Apr; 144(7):1685-1696. PubMed ID: 30478958
[TBL] [Abstract][Full Text] [Related]
14. Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition.
Raspaglio G; Buttarelli M; Filippetti F; Battaglia A; Buzzonetti A; Scambia G; Gallo D
Cell Death Dis; 2021 Oct; 12(10):933. PubMed ID: 34642300
[TBL] [Abstract][Full Text] [Related]
15. BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib.
Faraoni I; Compagnone M; Lavorgna S; Angelini DF; Cencioni MT; Piras E; Panetta P; Ottone T; Dolci S; Venditti A; Graziani G; Lo-Coco F
Biochim Biophys Acta; 2015 Mar; 1852(3):462-72. PubMed ID: 25483710
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
[TBL] [Abstract][Full Text] [Related]
17. Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient-Derived Xenograft Models.
Johnston ME; Rivas MP; Nicolle D; Gorse A; Gulati R; Kumbaji M; Weirauch MT; Bondoc A; Cairo S; Geller J; Tiao G; Timchenko N
Hepatology; 2021 Oct; 74(4):2201-2215. PubMed ID: 34037269
[TBL] [Abstract][Full Text] [Related]
18. Modulation of NF-κB in rescued irradiated cells.
Lam RK; Fung YK; Han W; Li L; Chiu SK; Cheng SH; Yu KN
Radiat Prot Dosimetry; 2015 Nov; 167(1-3):37-43. PubMed ID: 25911412
[TBL] [Abstract][Full Text] [Related]
19. PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.
Czyż M; Toma M; Gajos-Michniewicz A; Majchrzak K; Hoser G; Szemraj J; Nieborowska-Skorska M; Cheng P; Gritsyuk D; Levesque M; Dummer R; Sliwinski T; Skorski T
Oncotarget; 2016 Nov; 7(46):75551-75560. PubMed ID: 27705909
[TBL] [Abstract][Full Text] [Related]
20. Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma.
Chornenkyy Y; Agnihotri S; Yu M; Buczkowicz P; Rakopoulos P; Golbourn B; Garzia L; Siddaway R; Leung S; Rutka JT; Taylor MD; Dirks PB; Hawkins C
Mol Cancer Ther; 2015 Nov; 14(11):2560-8. PubMed ID: 26351319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]